Global Western blot detection Market Growth 2023-2029

Global Western blot detection Market Growth 2023-2029

The global Western blot detection market size is projected to grow from US$ 727.8 million in 2022 to US$ 1172.9 million in 2029; it is expected to grow at a CAGR of 7.1% from 2023 to 2029.

United States market for Western blot detection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Western blot detection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Western blot detection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Western blot detection players cover Thermo Fisher Scientific, Inc., GE HealthCare, F. Hoffmann-La Roche Ltd, Lumigen, Inc., Merck KGaA, Bio-Rad Laboratories, Inc., LI-COR, Inc., Bio-Techne and SBH Sciences, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

Western blotting is a laboratory technique used to detect a specific protein in a blood or tissue sample. The method involves using gel electrophoresis to separate the sample's proteins. The separated proteins are transferred out of the gel to the surface of a membrane. The membrane is exposed to an antibody specific to the target protein. The binding of the antibody is detected using a radioactive or chemical tag.

LPI (LP Information)' newest research report, the “Western blot detection Industry Forecast” looks at past sales and reviews total world Western blot detection sales in 2022, providing a comprehensive analysis by region and market sector of projected Western blot detection sales for 2023 through 2029. With Western blot detection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Western blot detection industry.

This Insight Report provides a comprehensive analysis of the global Western blot detection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Western blot detection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Western blot detection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Western blot detection and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Western blot detection.

This report presents a comprehensive overview, market shares, and growth opportunities of Western blot detection market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Fully Automatic
Semi Automatic

Segmentation by application
Diagnostic Laboratories
Research Institutions
Pharmaceutical & Biotechnology Companies

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific, Inc.
GE HealthCare
F. Hoffmann-La Roche Ltd
Lumigen, Inc.
Merck KGaA
Bio-Rad Laboratories, Inc.
LI-COR, Inc.
Bio-Techne
SBH Sciences
Advansta Inc.
Azure Biosystems Inc.
HiMedia Laboratories.
Elabscience Biotechnology Inc.
GenScript
Cell Signaling Technology, Inc.
ICL, Inc.
Takara Bio Inc.
Leinco Technologies

Key Questions Addressed in this Report

What is the 10-year outlook for the global Western blot detection market?

What factors are driving Western blot detection market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Western blot detection market opportunities vary by end market size?

How does Western blot detection break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.